At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which took place in Glasgow, Scotland, from 13 to 16 June 2025, the Danish pharmaceutical company ALK ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

because there is no known causal link between the use of Zicam Cold Remedy nasal gel and impairment of smell." The company said in a statement Tuesday that the safety of Zicam Cold Remedy is ...

Only mild taste sensations were reported in response to the nasal spray. Participants experienced no other adverse events. Bioavailability of just under 50 % in the pilot study showed that it was ...

Opioid Agonist Therapy Gap Coverage Program – This program provides immediate, no-cost coverage for certain OAT medications for 120 days, while you enrol in a supplementary health benefit plan.